It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas. ResearchAid now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.
Try our free search of constantly updated quotations and proverbs database.
Browse Authors:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
(Click a letter to view the authors)
Letter "C" » Catherine Arnold Quotes
(Click a letter to view the authors)
«We think the downside risk here is modest. Merck has fundamental challenges ahead based on its base business. We really concluded the stock is trading incorporating these items.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications. It (the U.K. ruling) is a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications, ... It [the U.K. ruling] is a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications, ... a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications. [The U.K. ruling] is a nice psychological boost, but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«This is half the savings that Pfizer achieved with its recently announced program.»
Author: Catherine Arnold
«After a long product portfolio transition, we forecast that Bristol-Myers could return to a period of sustained high teens earnings per share growth in 2007-2010.»
Author: Catherine Arnold
«We just can't get there. Maybe they see something we don't see.»
Author: Catherine Arnold
«Lilly's current valuation still provides an attractive entry point. The stock trades at a modest 8% to 10% premium to its peers against 2006 and 2007 earnings and at a discount against our 2008 to 2010 forecast.»
Author: Catherine Arnold
«Schering-Plough shares are most likely to be impacted by first quarter 2006 results.»
Author: Catherine Arnold
Research our database of over 800,000 top-quality pre-written papers plus 15,000 biographies for only $9.95/month.
Instant Account Activation. Register Now.
Instant Account Activation. Register Now.
